Provided by Tiger Trade Technology Pte. Ltd.

INVESCO BIOTECHNOLOGY & GENOME ETF

92.91
-0.1200-0.13%
Post-market: 92.910.00000.00%19:30 EDT
Volume:11.40K
Turnover:1.06M
Market Cap:403.23M
PE:51.81
High:93.97
Open:93.28
Low:92.77
Close:93.03
52wk High:98.82
52wk Low:67.69
Shares:4.34M
Float Shares:4.34M
Volume Ratio:1.07
T/O Rate:0.26%
Dividend:1.54
Dividend Rate:1.66%
EPS(TTM):1.79
EPS(LYR):18.65
ROE:24.76%
ROA:0.08%
PB:1.63
PE(LYR):4.98

Loading ...

Vertex Pharmaceuticals added to US Conviction List at Goldman Sachs

TIPRANKS
·
Sep 01

UK's Mhra : Informed Marketing Authorisation Holder of Decision to Suspend Use, Supply, Sale of Avacopan Vifor for New Patients from 1 September

THOMSON REUTERS
·
Sep 01

Why Is Amgen (AMGN) In Focus After New Repatha Survival Data?

Simply Wall St.
·
Sep 01

Vertex Advances Share Buyback, Acquires 445,500 Shares by August

TIPRANKS
·
Sep 01

Vertex (VRTX) Stock Looks Reasonable As Growth Must Justify Its Run

Simply Wall St.
·
Sep 01

Trump Administration Announces Drug Pricing Deals with CSL, Astellas and Others

Reuters
·
Sep 01

Biogen, Eisai announce positive recommendation for Leqembi in Canada

TIPRANKS
·
Sep 01

Eisai: Canada's Drug Agency Issues Final Positive Recommendation for Leqembi Reimbursement in Early Alzheimer's Disease

THOMSON REUTERS
·
Sep 01

Alnylam's Latest Data Strengthen Outlook for Nucresiran, TRITON-CM, Oppenheimer Says

MT Newswires Live
·
Aug 31

NASDAQ Top and Bottom Performing Stocks at About 11:01 A.m. EDT on 2026-08-31

Reuters
·
Aug 31

Political and General News Events from August 31

Reuters
·
Aug 31

Zenas BioPharma Highlights FDA Review Acceptance for Obexelimab IgG4-RD Filing in Corporate Presentation

Reuters
·
Aug 31

Analysts Conflicted on These Healthcare Names: Alnylam Pharma (ALNY), Lakefront Biotherapeutics (LKFT) and BioNTech SE (BNTX)

TIPRANKS
·
Aug 31

Amgen Says Repatha Cuts Death Risk 20% in High-Risk Patients

MT Newswires Live
·
Aug 31

Analysts Are Bullish on These Healthcare Stocks: Boston Scientific (BSX), Alnylam Pharma (ALNY)

TIPRANKS
·
Aug 31

Amgen Repatha reduces risk of death in high-risk adults for first heart attack

TIPRANKS
·
Aug 31

Amgen's Repatha® Reduces Risk of Death in Patients at High Risk for a First Heart Attack or Stroke

THOMSON REUTERS
·
Aug 31

Alnylam announces new data at ESC Congress on AMVUTTRA

TIPRANKS
·
Aug 31

Crinetics Shareholders Approve Vertex Acquisition at Special Meeting

TIPRANKS
·
Aug 29

Biogen Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Aug 29